AGREEMENT ---------Lease Agreement • March 31st, 1997 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Michigan
ESCROW AGREEMENT THIS ESCROW AGREEMENT (this "Agreement"), dated as of March 24, 1998, is by and among NaPro BioTherapeutics, Inc., a Delaware corporation ("NaPro"), Baker Norton Pharmaceuticals, Inc., a Florida corporation ("BNP"), and U.S. Bank...Escrow Agreement • March 26th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
March 20, 1998 NaPro BioTherapeutics, Inc. 6304 Spine Road Unit A Boulder, Colorado 80301 Attn: Vice President and Chief Financial Officer Gentlemen: Reference is made to (i) the Note Purchase Agreements (the "Purchase Agreements") dated as of May 30,...Note Purchase Agreement • April 8th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
ANDStock Purchase Agreement • October 5th, 1999 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Delaware
RECITALSEmployment Agreement • November 13th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Colorado
LOAN AND SECURITY AGREEMENT BY AND BETWEEN NAPRO BIOTHERAPEUTICS, INC. AND ABBOTT LABORATORIES JULY 23, 1999Loan and Security Agreement • October 5th, 1999 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Illinois
Annex III to Note Purchase Agreement PLEDGE AND SECURITY AGREEMENT ----------------------------- THIS PLEDGE AND SECURITY AGREEMENT, dated as of June 4, 1997 (this "Agreement"), by and between NAPRO BIOTHERAPEUTICS, INC., a Delaware corporation (the...Pledge and Security Agreement • August 14th, 1997 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
EXHIBIT 10.3 FORM OF WARRANT THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS IT HAS BEEN REGISTERED...Warrant Agreement • August 14th, 1997 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
and AMERICAN STOCK TRANSFER & TRUST COMPANY, as Rights Agent RIGHTS AGREEMENT Dated as of December 12, 2006Rights Agreement • December 14th, 2006 • Tapestry Pharmaceuticals, Inc • Medicinal chemicals & botanical products • Delaware
Certificates”) will be mailed to holders of record of the Common Shares as of the close of business on the Distribution Date and such separate Right Certificates alone will evidence the Rights.
R E C I T A L SLicense Agreement • April 2nd, 2001 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Delaware
RECITALSEmployment Agreement • April 14th, 2000 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Colorado
Exhibit 10.44 March 24, 1999Note Purchase Agreement • April 1st, 1999 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 6th, 2006 • Tapestry Pharmaceuticals, Inc • Medicinal chemicals & botanical products • New York
This Registration Rights Agreement (the “Agreement”) is made and entered into as of this day of , 2006 by and among Tapestry Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the “Investors” named in that certain Purchase Agreement by and among the Company and the Investors (the “Purchase Agreement”).
Exhibit 4.2 January 28, 1998 NaPro BioTherapeutics, Inc. Unit A 6304 Spine Road Boulder, Colorado 80301 Attn: Vice President and Chief Financial Officer Gentlemen: Reference is made to (i) the Subscription Agreement (the "Subscription Agreement")...Subscription Agreement • January 30th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
SUSPENSION NOTICE (Section 10(d) of Certificate of Designations of Series C Senior Convertible Preferred Stock)Subscription Agreement • June 23rd, 1999 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
March 31, 1998 NaPro BioTherapeutics, Inc. Unit A 6304 Spine Road Boulder, Colorado 80301 Attn: Vice President and Chief Financial Officer Gentlemen: Reference is made to (i) the Subscription Agreement (the "Subscription Agreement") dated as of...Subscription Agreement • April 8th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
LEASE AGREEMENTLease Agreement • April 2nd, 2001 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Ohio
CONFIDENTIAL DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT BY AND BETWEEN NAPRO BIOTHERAPEUTICS, INC.Development, License and Supply Agreement • October 5th, 1999 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Illinois
Exhibit 4.2 AGREEMENT IN PRINCIPLE THIS AGREEMENT IN PRINCIPLE, dated as of January 6, 1998 (this "Agreement"), by and between NAPRO BIOTHERAPEUTICS, INC., a Delaware corporation (the "Company"), and the undersigned holder (the "Holder") of one of the...Agreement in Principle • January 12th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
Exhibit 10.34 FORM OF SUBSCRIPTION AGREEMENT INCLUDING REGISTRATION RIGHTS NaPro BioTherapeutics, Inc. 6304 Spine Road, Unit A Boulder, Colorado 80301 Ladies and Gentlemen: The undersigned subscriber ("Subscriber") hereby tenders this Subscription...Subscription Agreement • April 2nd, 2001 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Delaware
EXHIBIT 10.2 FORM OF NOTE THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY STATE SECURITIES LAWS. THE SALE TO THE HOLDER OF THIS NOTE OF THE SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE...Senior Convertible Note • August 14th, 1997 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
Exhibit 99.3 March 20, 1998 Leonard P. Shaykin c/o NaPro BioTherapeutics, Inc. 6304 Spine Road, Unit A Boulder, Colorado 80301 NaPro BioTherapeutics, Inc. 6304 Spine Road, Unit A Boulder, Colorado 80301 Attn: Sterling K. Ainsworth Chief Executive...Warrant Purchase Agreement • March 26th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
This letter will confirm that, subject to (1) the execution and delivery of this letter by Shaykin and NaPro, (2) the execution and delivery of the Termination Agreement among IVAX, Baker Norton Pharmaceuticals, Inc., D&N and NaPro, by NaPro, and (3) the payment by Shaykin to D&N of $100,000 by wire transfer of immediately available funds to an account designated by D&N within 3 business days after the date of this letter, D&N agrees to forgive the indebtedness represented by Note, to cancel the Note and deliver it to Shaykin marked "canceled," and to deliver the Warrant, which D&N is holding on Shaykin's behalf, to NaPro for cancellation.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2004 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Colorado
THIS AGREEMENT (the "Agreement") is entered into effective as of this 22nd day of May, 2003 (the "Effective Date"), by and between NaPro BioTherapeutics, Inc., a Delaware corporation (the "Company"), and James D. McChesney, Ph.D. ("Executive"). Certain capitalized terms used in this Agreement have the meaning set forth in Paragraph 17 of this Agreement.
AMENDMENT TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 14th, 2000 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Delaware
RECITALS:Master Agreement • August 14th, 2000 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
Exhibit 99.1Termination Agreement • March 26th, 1998 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
STOCK OPTION AGREEMENT (NONSTATUTORY STOCK OPTION)Stock Option Agreement • December 4th, 2007 • Tapestry Pharmaceuticals, Inc • Medicinal chemicals & botanical products
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Tapestry Pharmaceuticals, Inc. (the “Company”) has granted you an option under its 2006 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 26th, 2004 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
This Common Stock Purchase Agreement (this "Agreement") is made and effective as of March 25, 2004 by and among NAPRO BIOTHERAPEUTICS, INC., a Delaware corporation (the "Company"), and the Purchasers identified in the signature pages attached hereto (each a "Purchaser", and collectively, the "Purchasers").
RIGHTS AGREEMENTRights Agreement • November 26th, 1996 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Delaware
March 24, 1999Subscription Agreement • April 1st, 1999 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 3rd, 2007 • Tapestry Pharmaceuticals, Inc • Medicinal chemicals & botanical products • Colorado
THIS AMENDED AND RESTATED AGREEMENT (the “Agreement”) is entered into effective as of this 28th day of March, 2007 (the “Effective Date”), by and between Tapestry Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Martin Batt (“Executive”). This Agreement amends, restates, and replaces in its entirety that employment agreement previously entered into between Tapestry and Executive as of October 28, 2005 (the “Original Agreement”). Certain capitalized terms used in this Agreement have the meaning set forth in Paragraph 17 of this Agreement.
STOCK OPTION AGREEMENT (INCENTIVE STOCK OPTION OR NONSTATUTORY STOCK OPTION)Stock Option Agreement • May 11th, 2006 • Tapestry Pharmaceuticals, Inc • Medicinal chemicals & botanical products
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Tapestry Pharmaceuticals, Inc. (the “Company”) has granted you an option under its 2006 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
EXHIBIT 4.6 FORM OF SUBSCRIPTION AGREEMENT DATED DECEMBER 8, 1997 SUBSCRIPTION AGREEMENT DATED AS OF DECEMBER 8, 1997 BY AND BETWEEN NAPRO BIOTHERAPEUTICS, INC.Subscription Agreement • December 16th, 1997 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Colorado
DATED AS OF NOVEMBER 8, 1996Rights Agreement • October 23rd, 2001 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • Delaware
EXHIBIT 10.1 FORM OF NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT, dated as of May 30, 1997 (this "Agreement"), by and between NAPRO BIOTHERAPEUTICS, INC., a Delaware corporation, with headquarters located at 6304 Spine Road, Unit A, Boulder,...Note Purchase Agreement • August 14th, 1997 • Napro Biotherapeutics Inc • Medicinal chemicals & botanical products • New York
